Utility of clinical chemical determinations of drug concentrations in biological fluids.
D000328:Adult; D000493:Allopurinol / Q000494:pharmacology; D000983:Antipyrine / Q000097:blood; D001259:Ataxia / Q000139:chemically induced; D002624:Chemistry, Clinical; D002849:Chromatography, Gas; D003069:Coffee; D003891:Desipramine / Q000097:blood; D001728:Dicumarol / Q000097:blood; D004336:Drug Antagonism; D004357:Drug Synergism; D000431:Ethanol / Q000378:metabolism / Q000494:pharmacology; D005260:Female; D005470:Fluorometry; D006207:Half-Life; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control*; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced; D008660:Metabolism / Q000187:drug effects; D008722:Methods; D008875:Middle Aged; D009020:Morphine / Q000097:blood; D009661:Nortriptyline / Q000097:blood; D009759:Nystagmus, Pathologic / Q000139:chemically induced; D004364:Pharmaceutical Preparations / Q000032:analysis / Q000097:blood* / Q000378:metabolism / Q000652:urine; D010597:Pharmacogenetics; D010600:Pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D010653:Phenylbutazone / Q000097:blood; D010672:Phenytoin / Q000009:adverse effects; D011247:Pregnancy; D012907:Smoking; D013053:Spectrophotometry; D014427:Twins; D014466:Ultraviolet Rays
D003069:Coffee; D004364:Pharmaceutical Preparations; D000431:Ethanol; D010672:Phenytoin; D000493:Allopurinol; D009020:Morphine; D001728:Dicumarol; D009661:Nortriptyline; D010653:Phenylbutazone; D000983:Antipyrine; D003891:Desipramine; D010634:Phenobarbital